6-bromo-3-[[3-bromo-4-[(2,4-dibromophenyl)methoxy]phenyl]methylideneamino]-2-methylquinazolin-4-one
C23H15Br4N3O2 — CID 126306062
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-bromo-3-[[3-bromo-4-[(2,4-dibromophenyl)methoxy]phenyl]methylideneamino]-2-methylquinazolin-4-one
6-bromo-3-[[3-bromo-4-[(2,4-dibromophenyl)methoxy]phenyl]methylideneamino]-2-methylquinazolin-4-one (PubChem CID 126306062) has the molecular formula C23H15Br4N3O2 and a molecular weight of 685.01 g/mol. Its IUPAC name is 6-bromo-3-[[3-bromo-4-[(2,4-dibromophenyl)methoxy]phenyl]methylideneamino]-2-methylquinazolin-4-one.
Molecular Properties
| Compound Name | 6-bromo-3-[[3-bromo-4-[(2,4-dibromophenyl)methoxy]phenyl]methylideneamino]-2-methylquinazolin-4-one |
|---|---|
| PubChem CID | 126306062 |
| Molecular Formula | C23H15Br4N3O2 |
| Molecular Weight | 685.01 g/mol |
| Exact Mass | 680.79 |
| IUPAC Name | 6-bromo-3-[[3-bromo-4-[(2,4-dibromophenyl)methoxy]phenyl]methylideneamino]-2-methylquinazolin-4-one |
| SMILES | Cc1nc2ccc(Br)cc2c(=O)n1N=Cc1ccc(OCc2ccc(Br)cc2Br)c(Br)c1 |
| InChI | InChI=1S/C23H15Br4N3O2/c1-13-29-21-6-5-16(24)9-18(21)23(31)30(13)28-11-14-2-7-22(20(27)8-14)32-12-15-3-4-17(25)10-19(15)26/h2-11H,12H2,1H3 |
| InChIKey | SXIINSKZINXFDU-UHFFFAOYSA-N |
| XLogP | 7.22 |
| TPSA | 56.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 685.01 |
| LogP ≤ 5 | 7.22 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126306062 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.